Is DOCS stock a Buy, Sell, or Hold?

Based on our analysis, DOCS is currently a HOLD with low confidence. 📊 HOLD: DOCS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of DOCS stock?

Our analysis estimates the fair value range for DOCS to be between $39.88 and $44.73. The current price is $37.47.

What is the analyst price target for DOCS?

The average Wall Street analyst price target for DOCS is $63.57. This implies a potential upside of 64.6% from current levels.

DOCS Stock Analysis: Buy, Sell, or Hold?

DOCS - Doximity, Inc.

SERVICES-COMPUTER PROGRAMMING SERVICES

$37.47

-1.16 (-3.00%) ▼

HOLD

LOW Confidence

Protect Your DOCS Gains

Last Updated: January 30, 2026

Earnings: Feb 05, 2026 4d

Get Alerted When DOCS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: DOCS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 9.9%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$60.31

Based on 7.0% avg growth

INTRINSIC VALUE TODAY

$37.45

Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: DOCS is currently trading at $37.47, which is considered oversold relative to its 30-day fair value range of $39.88 to $44.73. From a valuation perspective, the stock is trading at a discount (Forward PE: 22.4) compared to its historical average (28.8). Remarkably, the market is currently pricing in an annual earnings decline of 8.1% over the next few years. This pessimistic expectation contrasts with the company's recent 40.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, DOCS is in a strong downtrend. The price is currently testing key support at $37.33. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.0% recently.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $63.57 (+64.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD

Fair Price Range $39.88 - $44.73

Company Quality Score 55/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 74.8%

Protect Your Profits

Holding DOCS? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
NEUTRAL: Mixed technical signals (40/100)
BULLISH: High volume confirmation
BEARISH: Downward momentum (-3.0%)
BULLISH: Trading 64.6% below Wall St target ($63.57)
CAUTION: Recommendation downgraded due to -7.8% 5-day decline

Fair Price Analysis

30-Day Fair Range $39.88 - $44.73

Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $37.33

Resistance Level $42.13

Current Trend Strong Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 22.39

Wall Street Target $63.57 (+64.6%)

Revenue Growth (YoY) 23.2%

Earnings Growth (YoY) 40.9%

Profit Margin 40.7%

Valuation Discount vs History -8.1% cheaper

PE vs Historical 22.4 vs 28.8 CHEAP

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -8.1% (market-implied from PE analysis)

1-Year Target $35.50 (-8%)

2-Year Target $32.63 (-16%)

3-Year Target $29.98 (-22%)

3-Yr Target (if PE normalizes) (PE: 22→29) $38.57 (0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 22.4, Growth: 9.9%) $51.34 (+33%)

Base: (SPY PE: 22.3, Growth: 9.9%) $51.14 (+32%)

Bear: (PE: 19.0, Growth: 9.9%) $43.47 (+13%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (31x PE), but valuation improves significantly next year (22x PE) as earnings recover.

Trailing PE: 30.98 | Current EPS (TTM): $1.25

Bull Case $58.81 (+57%)

Analyst growth 38.0%, PE expands to 34.1

Base Case $53.47 (+43%)

Market implied 38.0%, PE stable at 31.0

Bear Case $26.34 (-30%)

Severe decline -20.0%, PE contracts to 26.3

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 22.4 to 28.8

Stabilization Target: $49.70 (+28.6%)

PE Expansion Potential: +28.6%

Last updated: January 31, 2026 1:46 AM ET
Data refreshes hourly during market hours. Next update: 2:46 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is DOCS showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Regina M Benjamin SELL 5000 shares 2025-10-10

Timothy S Cabral SELL 20000 shares 2025-09-24

Regina M Benjamin SELL 5000 shares 2025-09-12

View Insider Activity Scanner

Top Rated Health Information Services Stocks

Top-rated stocks in Health Information Services by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
VEEV Veeva Systems Inc Class A	BUY 32 analysts	$310	54 HOLD
PRVA Privia Health Group Inc	STRONG BUY 21 analysts	$31	57 HOLD
GEHC GE HealthCare Technologi…	STRONG BUY 21 analysts	$90	60 HOLD
PHR Phreesia Inc	STRONG BUY 15 analysts	$29	48 HOLD
HQY HealthEquity Inc	STRONG BUY 14 analysts	$119	55 HOLD

VEEV Veeva Systems Inc…

54 HOLD

PRVA Privia Health Gro…

57 HOLD

GEHC GE HealthCare Tec…

Advanced DOCS Option Strategies

Professional options setups generated by AI based on today's DOCS price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for DOCS

DOCS Technical Chart DOCS Price Prediction DOCS Earnings Date DOCS Investment Advisor DOCS Fair Price Analyzer DOCS Options Advisor DOCS Options Chain DOCS Options Analysis DOCS Competitors

Compare DOCS with Other Stocks

VRSN vs DOCS
Winner: VRSN

CYN vs DOCS

DOCS vs COMP

XTIA vs DOCS

Create New Comparison

Tradestie